You are here

AusPAR: Eculizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

2 December 2020
AusPAR Details
AusPAR
Active Ingredient
Eculizumab
Product Name
Soliris
Sponsor
Alexion Pharmaceuticals Australasia Pty Ltd
Submission Number
PM-2019-04825-1-1
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
24 November 2020
Publication Date

2 December 2020